Many artificial intelligence tools are used to manage different elements of content creation. However, for life sciences organizations, their needs are far more complex than most—ranging from writing scientific papers and explaining data from ongoing clinical trials to producing patient information brochures, among other use cases.
Without access to AI tools with scientific depth and rigorous accuracy, scaling these technologies has not been possible. Outsourcing these content tasks to traditional agencies remains an option, but the process is often slow due to the specialized nature of the work.
According to research from McKinsey & Company, nearly a quarter of life sciences organizations had already deployed GenAI at scale by 2025. However, scaling the technology had largely stalled, despite continued investment.
A new launch from Prezent AI could help life sciences companies and their agency partners solve this challenge and accelerate the pace of content delivery. The solution aims to power the entire life sciences communication ecosystem: Prezent Vivo.
The company, founded by Rajat Mishra, has built its business model around an AI-powered communications platform specializing in creating impactful presentations tailored to every audience.
Working with over 150 life sciences companies and 45 of the top 50 biopharma organizations has given Prezent a close-up view of the broader challenges industry leaders face when trying to scale AI tools for communication.
This led to the launch of Prezent Vivo, which supports the full content lifecycle through a purpose-built AI model combined with domain experts to strengthen biopharma communications.
Rather than replacing traditional agencies, Vivo helps teams meet the goals of biopharma companies by delivering content faster without compromising quality. It does so by combining the speed of AI with the oversight of subject matter experts.
“The future of Life Sciences communication is AI and experts, fused into one,” said Rajat Mishra, CEO and Co-Founder of Prezent.
The newly launched Vivo platform enables AI-powered communication at speed and scale across the entire spectrum of content deliverables. This includes the full product lifecycle, from congress posters and data visualization to scientific documents, brochures, MSL narrative decks, advisory board materials, national sales meetings, and more.
Francine Carrick, a 22-year MedComms veteran, has been appointed President to lead the new business for organizations.
Prezent’s original communication platform will continue to support presentation needs across industries. Vivo complements this core offering by delivering a broader range of communication outputs, along with deeper domain expertise tailored to the life sciences and biopharma sectors.
“I joined Prezent Vivo because I dreamt of a solution that would let the best people in MedComms bring more value to their clients,” said Carrick.
The technology behind Vivo
Prezent Vivo removes the limitations that have constrained AI adoption in the industry by combining purpose-built AI with embedded domain experts to deliver communications that are fast, cost-effective, scientifically precise, and compliant.
First, Astrid AI is an agent purpose-built for life sciences communication, trained on brand compliance requirements, regulatory language, clinical evidence structures, and both commercial and medical strategy contexts.
This is complemented by human experts—including presentation engineers, MedComms engineers, and medical writers—who bring scientific judgment and strategic narrative to ensure that communications are accurate, audience-ready, and reliable.
By combining both elements, the industry can finally benefit from the speed of AI-powered communication at scale without sacrificing precision or compliance.
The journey to launch Vivo has also been supported by Prezent’s expert advisory board.
Janet Dorling, Senior Vice President, US Commercial at Gilead Sciences and a member of Prezent’s Board of Directors, explains: “The Life Sciences organizations that will lead the next decade are the ones rethinking how science reaches its audiences. That rethink isn’t about replacing expertise with AI, or layering AI on top of old workflows. It’s about fusing the two from the ground up.”
The newly launched platform allows biopharma companies and agencies to access a self-service platform, request overnight services, or partner with experts on fixed-price projects. To learn more about Prezent Vivo, visit Prezent.ai.